LAERDAL HEARTSTART SAFETY ALERT TO BE DISCUSSED BY FDA AND USERS
This article was originally published in The Gray Sheet
Executive Summary
LAERDAL HEARTSTART SAFETY ALERT TO BE DISCUSSED BY FDA AND USERS at a July 18 meeting, according to the American Heart Association. FDA called the invitation-only meeting after users expressed concerns about the appropriateness of recommendations made in a January FDA safety alert on Laerdal automatic external defibrillators.